TSMC Exits Arm Holdings with $231 Million Share Sale Amid Strategic Portfolio Shift 
Novartis Q1 2026 Earnings Miss Expectations as Generic Competition Pressures Sales 
Qualcomm Stock Surges Despite Weak Guidance After Q2 2026 Earnings Beat 
Alphabet Earnings Surge on AI Growth, Cloud Revenue, and Strong Search Performance 
Samsung Reports Record Profit as AI Boom Drives Memory Chip Demand 
Microsoft Azure Growth Forecast Beats Expectations Amid Rising AI Competition 
Ford Q1 Earnings Beat Expectations, Stock Surges on Strong Guidance 
U.S. Cybersecurity Pushes Faster Patch Deadlines Amid Rising AI-Driven Threats 
Why Paycom Was Named a 2026 Platinum Employer on the Where You Work Matters List 
Amazon Stock Dips Despite Record Earnings as AI Infrastructure Spending Surges 
China’s Ultra-Cheap EV Boom: Why Electric Cars Cost Far Less Than in the U.S. 
Standard Chartered Q1 Profit Hits Record on Wealth and Investment Banking Growth 
T-Mobile Beats Q1 Earnings Expectations on Strong Postpaid Growth 
Starbucks Raises 2026 Outlook as Turnaround Strategy Boosts Sales and Earnings 
Nippon Express Stock Jumps as Elliott Investment Signals Strong Foreign Interest in Japan Logistics Sector 
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales 
Albany, NY, Jan. 18, 2016 (GLOBE NEWSWIRE) -- According to a new market research report published by Transparency Market Research Parenteral Nutrition Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2015 - 2023” the global parenteral nutrition market was valued at US$4.1 bn in 2014 and is estimated to reach a market value of US$6.9 bn by 2023 expanding at a CAGR of 5.7% from 2015 to 2023..
Parenteral nutrition (also known as intravenous feeding) is a method for the administration of nutritional supplement into the body through vein. Parenteral nutrition is used for the patients who cannot receive their nutrition requirements orally or have a non-functional gastrointestinal tract. Parenteral nutrition is commonly indicated for the patient’s with short bowel syndrome, crohn’s disease, ischemic bowel disease, cancer, diabetes and others. The parenteral nutrition marketis witnessing positive growth owing to the rising incidence of chronic disorders such as gastro-intestinal disorders, cancer, short bowel syndrome, ischemic bowel disease, Crohn’s disease, and renal failure. For example, according to the World Health Organization (WHO), cancer accounted for the leading cause of morbidity and mortality globally, with around 14 million new cases in 2012.
Recent Trends in the Market:
The organization stated that new cancer cases are expected to increase by 70% till 2025 to 2035. Thus, rising number of patients affected with chronic diseases fuels the demand for parenteral nutrition, leading to the market growth. However, side effects such as Catheter-related bloodstream infection, liver dysfunction and others with parenteral nutrition hamper the market growth to some extent. The global parenteral nutrition market was valued at US$ 4,097.4 Mn in 2014 and is expected to reach US$ 6,874.1 Mn by 2023, expanding at a CAGR of 5.7% from 2015 to 2023.
Browse Press Release of Parenteral Nutrition Market: http://www.transparencymarketresearch.com/pressrelease/parenteral-nutrition-market.htm
Rinsing use of dextrose as parenteral nutrition for premature babies is considered as the major driving factor for the growth of this segment. Single dose amino acids accounted for the largest share of the global parenteral nutrition market owing to the rising approval of novel single dose amino acid parenteral products by regulatory authorities. Parenteral lipid emulsion is projected to growth at the highest CAGR due to rising demand for this nutrient as it offers potential benefits as drug delivery vehicle. For example, administration of lipid emulsions act as essential drug carriers that results in reduced pain, irritation, and prevention of thrombophlebitis.
Key Players:
The global parenteral nutrition market is consolidated in which relatively small number of companies accounted for majority of market share. Companies such as Baxter International, Inc., Fresenius SE & Co. KGaA, B. Braun Melsungen AG, Hospira, Inc., Grifols S.A., Claris LifeSciences Limited and others are some of the key players having presence in the global parenteral nutrition market.
The global parenteral nutrition market is segmented as follows:
- Global Parenteral Nutrition Market, By Type of Nutrient
- Carbohydrates
- Parenteral Lipid Emulsion
- Single Dose Amino Acid Solutions
- Trace Elements
- Vitamins and Minerals
- Global Parenteral Nutrition Market, by Geography
- North America
- Europe
- Asia Pacific
- Latin America (LATAM)
- Middle East and Africa (MEA)
Other Reports by Transparency Market Research:
- Diabetes Devices and Drugs Market: http://www.transparencymarketresearch.com/diabetes-devices-market.html
- Liver Diseases Therapeutics Market: http://www.transparencymarketresearch.com/liver-diseases-therapeutics.html
About Us:
Transparency Market Research (TMR) is a U.S. based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
Mr.Sudip.S 90 State Street, Suite 700 Albany, NY 12207 United States. Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: [email protected] Website: http://www.transparencymarketresearch.com Blog: http://www.tmrblog.com/
